Related references
Note: Only part of the references are listed.Quantification of MET expression using mass spectrometry (MS): Assay precision and stability in FFPE tumor tissue
Todd A. Hembrough et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Toward personalized treatment for gastroesophageal adenocarcinoma (GEC): Strategies to address tumor heterogeneity-PANGEA
Daniel Virgil Thomas Catenacci et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Targeted Quantitation of Proteins by Mass Spectrometry
Daniel C. Liebler et al.
BIOCHEMISTRY (2013)
MET As a Possible Target for Non-Small-Cell Lung Cancer
Ahad A. Sadiq et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Level of HER2 Gene Amplification Predicts Response and Overall Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab
Carlos Gomez-Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non-Small-Cell Lung Cancer
David R. Spigel et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Application of Selected Reaction Monitoring for Multiplex Quantification of Clinically Validated Biomarkers in Formalin-Fixed, Paraffin-Embedded Tumor Tissue
Todd Hembrough et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer
Manish A. Shah et al.
PLOS ONE (2013)
MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome
H. E. Lee et al.
BRITISH JOURNAL OF CANCER (2012)
cMET and Phospho-cMET Protein Levels in Breast Cancers and Survival Outcomes
Kanwal P. Raghav et al.
CLINICAL CANCER RESEARCH (2012)
Targeting the HGF/Met signaling pathway in cancer therapy
Fabiola Cecchi et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer
Yuji Toiyama et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
MET: a promising anticancer therapeutic target
Solange Peters et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Targeting MET in cancer: rationale and progress
Ermanno Gherardi et al.
NATURE REVIEWS CANCER (2012)
RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma
Daniel V. T. Catenacci et al.
CANCER BIOLOGY & THERAPY (2011)
Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met
Keith W. Rickert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Discovery of a Novel Mode of Protein Kinase Inhibition Characterized by the Mechanism of Inhibition of Human Mesenchymal-epithelial Transition Factor (c-Met) Protein Autophosphorylation by ARQ 197
Sudharshan Eathiraj et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Genetic Activation of the MET Pathway and Prognosis of Patients With High-Risk, Radically Resected Gastric Cancer
Francesco Graziano et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
MET Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib
Jochen K. Lennerz et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Targeted mass spectrometry approaches for protein biomarker verification
Zhaojing Meng et al.
JOURNAL OF PROTEOMICS (2011)
Molecular Profiling of Cancer-The Future of Personalized Cancer Medicine: A Primer on Cancer Biology and the Tools Necessary to Bring Molecular Testing to the Clinic
Thomas Stricker et al.
SEMINARS IN ONCOLOGY (2011)
Durable Complete Response of Metastatic Gastric Cancer with Anti-Met Therapy Followed by Resistance at Recurrence
Daniel V. T. Catenacci et al.
CANCER DISCOVERY (2011)
In the clinic: ongoing clinical trials evaluating c-MET-inhibiting drugs
Neelesh Sharma et al.
Therapeutic Advances in Medical Oncology (2011)
Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
Alexa B. Turke et al.
CANCER CELL (2010)
MK-2461, a Novel Multitargeted Kinase Inhibitor, Preferentially Inhibits the Activated c-Met Receptor
Bo-Sheng Pan et al.
CANCER RESEARCH (2010)
BMS-777607, a Small-Molecule Met Kinase Inhibitor, Suppresses Hepatocyte Growth Factor-Stimulated Prostate Cancer Metastatic Phenotype In vitro
Yao Dai et al.
MOLECULAR CANCER THERAPEUTICS (2010)
MET signalling: principles and functions in development, organ regeneration and cancer
Livio Trusolino et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Correlations between RNA and protein expression profiles in 23 human cell lines
Marcus Gry et al.
BMC GENOMICS (2009)
Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer
Joseph Paul Eder et al.
CLINICAL CANCER RESEARCH (2009)
Targeting the c-MET signaling pathway for cancer therapy
Xiangdong Liu et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Expression and Mutational Analysis of MET in Human Solid Cancers
Patrick C. Ma et al.
GENES CHROMOSOMES & CANCER (2008)
Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesis
Laura P. Stabile et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Determinants of RNA Quality from FFPE Samples
Silke von Ahlfen et al.
PLOS ONE (2007)
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
Jeffrey A. Engelman et al.
SCIENCE (2007)
A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts
Neelu Puri et al.
CANCER RESEARCH (2007)
c-Met ectodomain shedding rate correlates with malignant potential
Gagani Athauda et al.
CLINICAL CANCER RESEARCH (2006)
Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752
GA Smolen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma
LJ Herrera et al.
NEOPLASIA (2005)
Influence of slide aging on results of translational research studies using immunohistochemistry
M Mirlacher et al.
MODERN PATHOLOGY (2004)
Tissue microarrays in drug discovery
G Sauter et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Share Paper
